Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

Background Despite a lack of clinical evidence, hydroxychloroquine and azithromycin are being administered widely to patients with verified or suspected coronavirus disease 2019 (COVID‐19). Both drugs may increase risk of lethal arrhythmias associated with QT interval prolongation. Methods and Resul...

Full description

Bibliographic Details
Main Authors: Archana Ramireddy, Harpriya Chugh, Kyndaron Reinier, Joseph Ebinger, Eunice Park, Michael Thompson, Eugenio Cingolani, Susan Cheng, Eduardo Marban, Christine M. Albert, Sumeet S. Chugh
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
azithromycin
COVID‐19
hydroxychloroquine
monitoring
QT interval
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.017144

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.017144

Similar Items